After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Puma Biotechnology Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Puma Biotechnology Inc is $269.49M. A total of 0.74 million shares were traded on the day, compared to an average of 616.15K shares.
In the most recent transaction, AUERBACH ALAN H sold 41,396 shares of PBYI for 4.49 per share on Jan 03 ’24. After the transaction, the President and CEO now owns 6,936,947 company shares. In a previous transaction on Jan 03 ’24, NOUGUES MAXIMO F sold 15,682 shares at 4.49 per share. PBYI shares that Chief Financial Officer owns now total 128,666.
Among the insiders who sold shares, Ludwig Jeffrey Jerome disposed of 12,956 shares on Jan 03 ’24 at a per-share price of $4.49. This resulted in the Chief Commercial Officer holding 99,970 shares of PBYI after the transaction. In another insider transaction, HUNT DOUGLAS M sold 8,358 shares at $4.49 per share on Jan 03 ’24. Company shares held by the insider now total 103,319.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PBYI has a high of $7.73 and a low of $2.13.
As of this writing, PBYI has an earnings estimate of -$0.22 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.21 per share and a lower estimate of -$0.23. The company reported an EPS of $0.12 in the last quarter, which was 50.00% higher than expectations of $0.08.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PBYI’s latest balance sheet shows that the firm has $82.11M in Cash & Short Term Investments as of fiscal 2021. There were $116.64M in debt and $109.59M in liabilities at the time. Its Book Value Per Share was $1.12, while its Total Shareholder’s Equity was -$2.45M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PBYI is Buy with a score of 3.33.
